LSP passes target with €150m close

Life Science Partners has increased its assets under management to $500m following a final close of its third venture capital fund, LSP III, at €150m.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this